1. Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
   Juan Garona et al, 2016, Clinical & Experimental Metastasis CrossRef
2. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
   Juan Garona et al, 2019, Cancer Research and Treatment CrossRef
3. Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent
   Juan Garona et al, 2020, Vasopressin CrossRef
4. Exploiting cancer’s phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy
   Mahjabin Khan et al, 2017, Oncotarget CrossRef
5. Neurohormonal Regulation of Tumor Growth
   I. I. Khegai, 2018, Russian Journal of Genetics CrossRef
6. Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
   Laine M. Heidman et al, 2022, Molecular Cancer Research CrossRef
7. In vitroandin vivoevaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment
   Merari T Chevalier et al, 2018, Nanomedicine CrossRef
8. Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches
   Marina Pifano et al, 2018, Future Medicinal Chemistry CrossRef
9. Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
   Marina Pifano et al, 2017, Frontiers in Oncology CrossRef
10. Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus
    Beril Erdem Tuncdemir, 2022, Journal of Receptors and Signal Transduction CrossRef
11. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
    JUAN GARONA et al, 2015, International Journal of Oncology CrossRef
12. Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
    Mladena Glavaš et al, 2022, International Journal of Molecular Sciences CrossRef